En Es
Categories

FUJIREBIO

FUJIREBIO

Fujirebio is a global leader in the field of IVD testing with more than 50 years’ experience in the conception, development, production and worldwide commercialization of robust IVD products. These span the range from specialized testing to fully automated routine clinical laboratory testing solutions covering a variet...
Gold member
Products Summary
Close

About FUJIREBIO

Fujirebio is a global leader in the field of IVD testing with more than 50 years’ experience in the conception, development, production and worldwide commercialization of robust IVD products. These span the range from specialized testing to fully automated routine clinical laboratory testing solutions covering a variety of disease states.

Recently updated

Assay
INNO-LiPA CFTR Extra

The INNO-LiPA CFTR Extra is an assay for the detection of 18 new disease-causing cystic fibrosis (CF) mutations with a high frequency in local European regions. With the new product, Fujirebio now offers a total of 88 disease-causing mutations and optional poly T testing, increasing the overall detection rate for cystic fibrosis to at least 91,8%.
More details

Immunoassays
INNOTEST

The INNOTEST assays are solid-phase enzyme immunoassays for the quantitative determination of β-amyloid (1-42), β-amyloid (1-40), total Tau, and phospho-Tau (181P) in human cerebrospinal fluid. The combined use of these markers allows identification of AD pathology ante-mortem in order to discriminate AD from normal aging, other neurological diseases and other types of dementia (non-AD).
More details

Chemiluminescent Enzyme Immunoassay
Lumipulse G HE4

The Lumipulse G HE4 is a Chemiluminescent Enzyme Immunoassay (CLEIA) for in vitro diagnostics (IVD) use for the quantitative measurement of HE4 (Human epididymis protein 4) in human serum or plasma (sodium heparin, lithium heparin, or dipotassium EDTA) on the LUMIPULSE G system. The assay is the first new biomarker in 30 years for ovarian cancer management and utilizes proven CLEIA technology to deliver results in up to 35 minutes.
More details

Clinical Laboratory

Assay
INNO-LiPA CFTR Extra

The INNO-LiPA CFTR Extra is an assay for the detection of 18 new disease-causing cystic fibrosis (CF) mutations with a high frequency in local European regions. With the new product, Fujirebio now offers a total of 88 disease-causing mutations and optional poly T testing, increasing the overall detection rate for cystic fibrosis to at least 91,8%.
More details

Immunoassays
INNOTEST

The INNOTEST assays are solid-phase enzyme immunoassays for the quantitative determination of β-amyloid (1-42), β-amyloid (1-40), total Tau, and phospho-Tau (181P) in human cerebrospinal fluid. The combined use of these markers allows identification of AD pathology ante-mortem in order to discriminate AD from normal aging, other neurological diseases and other types of dementia (non-AD).
More details

Chemiluminescent Enzyme Immunoassay
Lumipulse G HE4

The Lumipulse G HE4 is a Chemiluminescent Enzyme Immunoassay (CLEIA) for in vitro diagnostics (IVD) use for the quantitative measurement of HE4 (Human epididymis protein 4) in human serum or plasma (sodium heparin, lithium heparin, or dipotassium EDTA) on the LUMIPULSE G system. The assay is the first new biomarker in 30 years for ovarian cancer management and utilizes proven CLEIA technology to deliver results in up to 35 minutes.
More details

Immunoassay Test
INNO-LiPA HPV Genotyping Extra II (20T)

The INNO-LiPA HPV Genotyping Extra II (20T) line immunoassay is intended for the individual identification of 32 HPV genotypes. It comes with easy and ready-to-use master mix along with Taq DNA polymerase for minimum manipulation steps and hands-on time.
More details

Immunoassay Test
INNO-LIA HIV I/II Score (20T)

The INNO-LIA HIV I/II Score (20T) line immunoassay is intended for the confirmation and discrimination of antibodies to HIV-1, HIV-1 group O and HIV-2 in human serum and plasma. All major HIV strains are detectable with one strip in short and overnight procedures with an optimal specificity of 96.7% (290/300) in screened-negative blood donors.
More details

PCT Assay
Lumipulse G B•R•A•H•M•S PCT Assay

The Lumipulse G B•R•A•H•M•S PCT is a Chemiluminescent Enzyme Immunoassay (CLEIA) for the quantitative determination of PCT (procalcitonin) in human serum and plasma (sodium heparin, lithium heparin, sodium citrate or dipotassium EDTA) on the LUMIPULSE G System. It offers excellent precision with a CV of ≤4.7% with results available in up to 35 minutes, making it an ideal aid for decision-making in patients with suspected or confirmed lower respiratory tract infection.
More details

Immunoassay Analyzer
TENDIGO

The TENDIGO immunoassay analyzer turns daily manual work into automation for low throughput testing volumes with validated INNO-LIA and INNO-LIPA assay protocols on board and open protocol programming. Other features include easy operation, minimum hands-on time, walkaway principle, and dry heating on board for fast and accurate processing.
More details

Immunoassay Test
Lumipulse G HTLV-I/II

The Lumipulse G HTLV-I/II is meant for in vitro diagnostic use with the LUMIPULSE G System for qualitative detection of antibody to HTLV-I and HTLV-II in human serum or plasma for screening of HTLV-I/II viral infection. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme ImmunoAssay) technology with results that are available in up to 35 minutes.
More details

CLEIA Analyzer
LUMIPULSE G600 II

The LUMIPULSE G600II, the latest member of the LUMIPULSE G series chemiluminescent enzyme immunoassay (CLEIA) analyzers from Fujirebio, uses a unique mono test cartridge concept and features a constant throughput of 60 tests per hour. The compact and robust benchtop analyzer provides a perfect fit in hospitals and clinical laboratories aiming for personalized workflow solutions without compromising testing quality, offering outstanding flexibility and easy handling.
More details

CLEIA Analyzer
LUMIPULSE G1200

The LUMIPULSE G1200 is a robust mid-sized fully automated immunoassay instrument that uses a unique mono test cartridge concept and performs a true throughput of 120 tests per hour. A member of Fujirebio’s already widely successful LUMIPULSE G series, it provides outstanding flexibility and easy handling in hospitals and clinical laboratories.
More details
Copyright © 2000-2019 TradeMed.com. All rights reserved. | Terms And Conditions